Dr Reddys Laboratories RDY
NYSE RDY
$15.05 +0.15 (+1.01%)
At close: Nov 9, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Return on Invested Capital [ROIC] of 5.62% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 7.73 percentage points from 13.35% a year earlier and down 1.14 percentage points from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Return on Invested Capital [ROIC] came in at 9.49%, down 6.02 percentage points from FY2025.

  • Annual Return on Invested Capital [ROIC] shows a five-year change of +1.02 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Dr Reddys Laboratories' Return on Invested Capital [ROIC] was 15.50% in FY2025 (-3.64 pp), 19.14% in FY2024 (+1.66 pp), 17.48% in FY2023 (+7.58 pp) and 9.90% in FY2022 (+1.43 pp).
  • The fiscal Q2 2027 figure stands as the lowest quarterly Return on Invested Capital [ROIC] since fiscal Q4 2015.
  • On a year-over-year basis, Return on Invested Capital [ROIC] has declined in each of the last 11 quarters, with an average year-over-year change of -4.36 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was fiscal Q4 2023, with a gain of 9.96 percentage points; the weakest was fiscal Q2 2027, with a drop of 7.73 percentage points.
  • According to Business Quant data, Return on Invested Capital [ROIC] for the three prior fiscal quarters was 6.77% (Q1 2027), 9.10% (Q4 2026) and 12.15% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.57%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 24.28%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.88%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 24.11%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 15.60%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.11%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 12.34%
10 Dr Reddys Laboratories 12.52 Bn 11.86 Bn 472.93 Mn 5.62%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.62%
Jun 30, 2026 6.77%
Mar 31, 2026 9.10%
Dec 31, 2025 12.15%
Sep 30, 2025 13.35%
Jun 30, 2025 13.51%
Mar 31, 2025 14.32%
Dec 31, 2024 14.33%
Sep 30, 2024 14.88%
Jun 30, 2024 16.76%
Mar 31, 2024 17.70%
Dec 31, 2023 19.14%
Sep 30, 2023 18.72%
Jun 30, 2023 18.98%
Mar 31, 2023 18.90%
Dec 31, 2022 13.94%
Sep 30, 2022 11.70%
Jun 30, 2022 9.24%
Mar 31, 2022 8.94%
Dec 31, 2021 11.28%
API Access

Dr Reddys Laboratories Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY